Binding conformations, QSAR, and molecular design of Alkene-3-quinolinecarbonitriles as Src inhibitors

被引:12
作者
Zeng, G. H. [1 ]
Fang, D. Q. [2 ]
Wu, W. J. [1 ]
Zhang, R. [1 ]
Xie, W. G. [1 ]
Wu, J. H. [3 ]
Shen, Y. [3 ]
机构
[1] Guangdong Pharmaceut Univ, Coll Pharm, Dept Phys Chem, Guangzhou 510006, Guangdong, Peoples R China
[2] Guangzhou Med Univ, Dept Cardiothorac Surg, Affiliated Hosp 2, Guangzhou 510260, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Sch Chem & Chem Engn, Guangzhou 510275, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Src inhibitor; alkene-3-quinolinecarbonitriles; three-dimensional quantitative structureactivity relationship; docking study; NATURAL-POPULATION ANALYSIS; KINASE INHIBITOR; TYROSINE KINASE; ABL KINASES; ORBITAL ELECTRONEGATIVITY; QUANTITATIVE STRUCTURE; FIELD ANALYSIS; COMSIA MODELS; BCR-ABL; C-SRC;
D O I
10.1002/qua.24344
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070305 [高分子化学与物理];
摘要
A theoretical study on binding orientations and quantitative structureactivity relationship (QSAR) of a novel series of alkene-3-quinolinecarbonitriles acting as Src inhibitors has been carried out by using the docking study and three-dimensional QSAR (3D-QSAR) analyses. The appropriate binding orientations and conformations of these compounds interacting with Src kinase were revealed by the docking studies, and the established 3D-QSAR models show significant statistical quality and satisfactory predictive ability, with high R-2 values and q(2) values: comparative molecular field analysis (CoMFA) model (q(2) = 0.748, R-2 = 0.972), comparative molecular similarity indices analysis (CoMSIA) model (q(2) = 0.731, R-2 = 0.987). The systemic external validation indicated that both CoMFA and CoMSIA models possessed high predictive powers with R-pred(2) values of 0.818 and 0.892, r(m)(2) values of 0.879 and 0.886, r(m(LOO)(2)) values of 0.874 and 0.874, r(m(overall))(2) values of 0.879 and 0.885, respectively. Several key structural features of the compounds responsible for inhibitory activity were discussed in detail. Based on these structural factors, eight new compounds with quite higher predicted Src-inhibitory activities have been designed and presented. We hope these theoretical results can offer some valuable references for the pharmaceutical molecular design as well as the action mechanism analysis. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:1467 / 1478
页数:12
相关论文
共 55 条
[1]
Ali A, 2006, BIOORGAN MED CHEM, V14, P1474
[2]
[Anonymous], 2010, CHEM3D SOFTW
[3]
Development of CoMFA and CoMSIA models of cytotoxicity data of anti-HIV-1-phenylamino-1H-imidazole derivatives [J].
Basu, Arijit ;
Jasu, Kalsariya ;
Jayaprakash, Venkatesan ;
Mishra, Nibha ;
Ojha, P. ;
Bhattacharya, S. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (06) :2400-2407
[4]
Bhoomendra A. B., 2005, BIOORGAN MED CHEM, V13, P2773
[5]
7-alkoxy-4-phenylamino-3-quinolinecarbonitriles as dual inhibitors of Src and Abl kinases [J].
Boschelli, DH ;
Wang, YND ;
Johnson, S ;
Wu, BQ ;
Ye, F ;
Sosa, ACB ;
Golas, JM ;
Boschelli, F .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (07) :1599-1601
[6]
Bosutinib -: Dual Src and Abl kinase inhibitor treatment of solid tumors treatment of CML and Ph+ ALL [J].
Boschelli, Diane H. ;
Boschelli, Frank .
DRUGS OF THE FUTURE, 2007, 32 (06) :481-490
[7]
Optimization of 7-alkene-3-quinolinecarbonitriles as Src kinase inhibitors [J].
Boschelli, Diane H. ;
Wang, Daniel ;
Wang, Yan ;
Wu, Biqi ;
Honores, Erick E. ;
Sosa, Ana Carolina Barrios ;
Chaudhary, Inder ;
Golas, Jennifer ;
Lucas, Judy ;
Boschelli, Frank .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (09) :2924-2927
[8]
Further studies on ethenyl and ethynyl-4-phenylamino-3-quinolinecarbonitriles: identification of a subnanomolar Src kinase inhibitor [J].
Carolina, A ;
Sosa, B ;
Boschelli, DH ;
Wu, BQ ;
Wang, Y ;
Golas, JM .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (06) :1743-1747
[9]
Src tyrosine kinase as a chemotherapeutic target: is there a clinical case? [J].
Chen, Ting ;
George, Jessica A. ;
Taylor, Christopher C. .
ANTI-CANCER DRUGS, 2006, 17 (02) :123-131
[10]
CROSS-VALIDATED R(2)-GUIDED REGION SELECTION FOR COMPARATIVE MOLECULAR-FIELD ANALYSIS - A SIMPLE METHOD TO ACHIEVE CONSISTENT RESULTS [J].
CHO, SJ ;
TROPSHA, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (07) :1060-1066